Appleton Partners Portfolio holdings
Appleton Partners is an employee-owned investment firm that specializes in municipal bonds, taxable bonds and stocks for individuals, families and institutions. Douglas Chamberlain co-founded it in 1986 and is its president and chief executive. Before that he was a research director, portfolio manager and trust investment officer. Its custom portfolios serve families, charities and city or state governments. It also manages accounts for other advisers and financial firms. Its investment teams rely on fundamental analysis, backed by economic and technical insights.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.94M |
| 2 |
AGN
Allergan plc
AGN
|
+$3.03M |
| 3 |
Amazon
AMZN
|
+$2.76M |
| 4 |
Broadcom
AVGO
|
+$1.42M |
| 5 |
Dollar Tree
DLTR
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$4.25M |
| 2 |
Citigroup
C
|
+$3.43M |
| 3 |
Under Armour
UAA
|
+$1.91M |
| 4 |
Gilead Sciences
GILD
|
+$1.44M |
| 5 |
Roper Technologies
ROP
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.85% |
| 2 | Financials | 15.07% |
| 3 | Technology | 13.59% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Consumer Staples | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
76
Aptiv
APTV
$7.84B
| $1.56M | 0.32% |
24,939
-60,871
| -71% | -$4.25M |
2014 Q2
8 quarters
|
|
77
Cardinal Health
CAH
$65B
| $1.55M | 0.32% |
19,878
-3,500
| -15% | -$279K |
2015 Q3
3 quarters
|
|
78
Intel
INTC
$317B
| $1.54M | 0.32% |
46,980
-3,349
| -7% | -$105K |
2013 Q2
12 quarters
|
|
79
Union Pacific
UNP
$180B
| $1.52M | 0.31% |
17,470
-2,168
| -11% | -$183K |
2013 Q3
11 quarters
|
|
80
DELISTED
Electronic Arts
EA
| $1.5M | 0.31% |
19,815
+2,960
| +18% | +$208K |
2015 Q4
2 quarters
|
|
81
PNC Financial Services
PNC
$92.3B
| $1.5M | 0.31% |
18,408
-715
| -4% | -$61.5K |
2014 Q1
9 quarters
|
|
82
Illumina
ILMN
$31.3B
| $1.45M | 0.3% |
10,614
-9,272
| -47% | -$1.32M |
2015 Q1
5 quarters
|
|
83
Coca-Cola
KO
$427B
| $1.41M | 0.29% |
31,131
-647
| -2% | -$29.2K |
2013 Q2
12 quarters
|
|
84
Abbott
ABT
$188B
| $1.39M | 0.28% |
35,388
-269
| -0.8% | -$10.7K |
2013 Q2
12 quarters
|
|
85
Amphenol
APH
$193B
| $1.35M | 0.28% |
188,752
-7,192
| -4% | -$51.7K |
2013 Q2
12 quarters
|
|
86
Honeywell
HON
$70.6B
| $1.28M | 0.26% |
12,292
+351
| +3% | +$36.1K |
2013 Q2
12 quarters
|
|
87
Church & Dwight Co
CHD
$26.7B
| $1.27M | 0.26% |
24,652
-200
| -0.8% | -$9.7K |
2013 Q2
12 quarters
|
|
88
Target
TGT
$73.3B
| $1.22M | 0.25% |
17,550
| – | – |
2013 Q2
12 quarters
|
|
|
RTN
89
DELISTED
Raytheon Company
RTN
| $1.19M | 0.24% |
8,726
+101
| +1% | +$13.2K |
2013 Q2
12 quarters
|
|
90
AT&T
T
$149B
| $1.18M | 0.24% |
36,033
+1,490
| +4% | +$44.3K |
2013 Q2
12 quarters
|
|
91
Applied Materials
AMAT
$294B
| $1.15M | 0.24% |
48,010
+660
| +1% | +$14.6K |
2015 Q4
2 quarters
|
|
92
RTX Corp
RTX
$268B
| $1.15M | 0.24% |
17,838
-370
| -2% | -$23.7K |
2013 Q2
12 quarters
|
|
93
ScottsMiracle-Gro
SMG
$3.72B
| $1.12M | 0.23% |
16,008
-540
| -3% | -$37.5K |
2013 Q2
12 quarters
|
|
94
Texas Instruments
TXN
$277B
| $1.09M | 0.22% |
17,448
+424
| +2% | +$25.2K |
2014 Q1
9 quarters
|
|
95
VF Corp
VFC
$8.14B
| $1.09M | 0.22% |
18,836
-2,547
| -12% | -$151K |
2013 Q2
12 quarters
|
|
96
Digital Realty Trust
DLR
$68.1B
| $1.08M | 0.22% |
9,941
+603
| +6% | +$57.2K |
2015 Q4
2 quarters
|
|
97
Novartis
NVS
$303B
| $1.04M | 0.21% |
14,059
-2,372
| -14% | -$164K |
2013 Q2
12 quarters
|
|
98
Automatic Data Processing
ADP
$122B
| $1.04M | 0.21% |
11,267
| – | – |
2013 Q3
11 quarters
|
|
99
Nike
NKE
$56.4B
| $1.01M | 0.21% |
18,292
-2,800
| -13% | -$160K |
2013 Q3
11 quarters
|
|
100
Stryker
SYK
$118B
| $992K | 0.2% |
8,281
+3,836
| +86% | +$429K |
2015 Q4
2 quarters
|
|
Similar funds
Appleton Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Appleton Partners held 214 positions worth $489M, down 3.3% from $506M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Appleton Partners withdrew a net $15M in Q2 2016, closing 10 positions and reducing 123 holdings. Its most notable exit was Perrigo, an estimated $412K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
Against the trend, Appleton Partners opened a new position in UnitedHealth worth $4.17M.
- Appleton Partners's largest Q2 2016 buy was UnitedHealth: 29,523 shares worth $4.17M.
- Appleton Partners added most to Allergan plc in Q2 2016, an estimated $3.03M increase.
- Appleton Partners's biggest Q2 2016 reduction was Aptiv, cutting an estimated $4.25M.
- Appleton Partners fully exited Perrigo in Q2 2016, selling an estimated $412K.
- Appleton Partners's ten largest holdings make up 23% of its $489M portfolio in Q2 2016.
- Appleton Partners opened 8 new positions and closed 10 in Q2 2016.
- Appleton Partners's portfolio value fell 3.3% quarter-over-quarter to $489M.
Based on Appleton Partners's 13F filing for Q2 2016, filed 3 Aug 2016.